Author Information
Klaus Rostgaard is a distinguished researcher affiliated with the Department of Epidemiology Research at the Statens Serum Institut in Copenhagen, Denmark. His work primarily focuses on epidemiology, contributing significantly to various fields including chronic lymphocytic leukemia, atopic respiratory diseases, and the impact of pharmacological prescriptions.Research Contributions
Klaus Rostgaard has made substantial contributions to the field of epidemiology through his extensive research. His recent works include studies on the clinical significance of aetiological heterogeneity in classical Hodgkin lymphoma, the prediction of IgE sensitization based on combinations of self-reported rhinitis, conjunctivitis, and asthma, and the mapping of comorbidities in chronic lymphocytic leukemia. His research extends to understanding the risk of new malignancies among patients treated with chemotherapy, as well as investigating the incidence and remission rates of self-reported hidradenitis suppurativa. Additionally, he has examined childcare attendance and its correlation with the risk of infectious mononucleosis, and the impact of atopic respiratory diseases on leukocyte subset concentrations. His work also delves into pharmacoepidemiological methods and the effects of health-related quality of life on blood donor careers. Notably, he has researched the outcomes of preterm birth, stillbirth, and early neonatal mortality during the Danish COVID-19 lockdown.Aliases
Klaus Rostgaard is also known by several aliases, including K Rostgaard and K. Rostgaard.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
7392 |
| h-index |
50 |
| Paper Count |
204 |
